Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.
Laurelle JacksonJessica HunterSandile CeleIsabella Markham FerreiraAndrew C YoungFarina KarimRajhmun MadanseinKaylesh J DullabhChih-Yuan ChenNoel J BuckelsYashica GangaKhadija KhanMikael BoulleGila LustigRichard A NeherAlex SigalPublished in: eLife (2018)
HIV has been reported to be cytotoxic in vitro and in lymph node infection models. Using a computational approach, we found that partial inhibition of transmissions of multiple virions per cell could lead to increased numbers of live infected cells. If the number of viral DNA copies remains above one after inhibition, then eliminating the surplus viral copies reduces cell death. Using a cell line, we observed increased numbers of live infected cells when infection was partially inhibited with the antiretroviral efavirenz or neutralizing antibody. We then used efavirenz at concentrations reported in lymph nodes to inhibit lymph node infection by partially resistant HIV mutants. We observed more live infected lymph node cells, but with fewer HIV DNA copies per cell, relative to no drug. Hence, counterintuitively, limited attenuation of HIV transmission per cell may increase live infected cell numbers in environments where the force of infection is high.
Keyphrases
- lymph node
- hiv infected
- antiretroviral therapy
- cell cycle arrest
- cell death
- hiv positive
- induced apoptosis
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- hiv testing
- single cell
- neoadjuvant chemotherapy
- sentinel lymph node
- hepatitis c virus
- cell therapy
- men who have sex with men
- sars cov
- single molecule
- endoplasmic reticulum stress
- radiation therapy
- oxidative stress
- early stage
- squamous cell carcinoma
- stem cells
- circulating tumor
- south africa
- circulating tumor cells